Maxime Tarabichi
@MaxGalder
Followers
241
Following
682
Media
2
Statuses
369
👶🧒👦🧔; 👨🎓👨💻👨👩👦👦; ⚽️🎸(🌕🍊📡); 🇧🇪💞🇩🇪; he/him.
Brussels/Bonn
Joined May 2016
RT @inigo_landa: We are hiring a Senior Research Assistant to join my lab at Gustave Roussy. Please see job description below and, if inter….
0
1
0
🚨 Postdoc Opportunity 🚨.If you’re a molecular biologist interested in somatic evolution and cancer, my lab has an open postdoc position 🧬🔬. Apply here: .#Postdoc #CancerResearch #MolecularBiology #Genomics.
1
1
2
RT @FabPucci: Are residue conservation and solvent accessibility all you need for predicting the impact of mutations on proteins? Have a lo….
0
3
0
ERC-funded 3-year postdoctoral position in bioinformatics looking at cancer epigenomics/epitranscriptomics available in the Jeschke lab at Bordet Institute:.
0
1
0
RT @TimCoorens: Very happy and excited to announce that I'll be starting my own research group at @emblebi! The group will focus on lineage….
0
31
0
RT @CD_AACR: From the October issue: The History of Chromosomal Instability in Genome Doubled Tumors - by Toby Baker, @MaxGalder, @VanLooL….
0
5
0
RT @ElizSMcKenna: The October issue of @CD_AACR is online! The cover features features work by @TobyBaker97, @MaxGalder, @VanLooLab and co….
0
3
0
Visionary scientist who’s been a driving force in cancer genomics and somatic evolution! Can’t wait to see what they’ll cook up at Quotient with all that brainpower!.
Peter Campbell leaves the Sanger Institute at the end of the year to become Quotient's CSO. A mentor and one of my favourite scientists. His foundational, profound and creative contributions to cancer genomics and somatic evolution have truly shaped those fields. [1/7].
0
0
8
RT @deniswirtz: Our new paper on 3D single-cell mapping of immune cells near pre-cancer lesions using CODA in a video. Watch until the end….
0
52
0
RT @davidcwedge: We published today a study of Whole Genome Sequencing from over 2000 colorectal cancers from the Genomics England cohort.….
0
12
0
RT @AndreaSottoriva: Does cancer #evolution & intra-tumour heterogeneity predict long-term relapse? We tested the evolutionary paradigm in….
0
80
0
RT @FabPucci: PhD position available here in Bruxelles to work with us @MaxGalder @mariannerooman on #AI4Cancer, Leveraging AI to study #Ca….
0
3
0
RT @heatherEmachado: I’m thrilled to shared that this August I’ll join the Department of Pathology of the University of Cambridge @Cambrid….
0
16
0
RT @VanLooLab: 🚀 Excited to share our latest research! We developed GRITIC, a novel method for timing genomic gains using bulk WGS data. Ou….
0
27
0
RT @ElizSMcKenna: Now online in @CD_AACR: The History of Chromosomal Instability in Genome Doubled Tumors - by Toby Baker, @MaxGalder, @Va….
0
29
0
RT @chiarabatini: Application deadline for our @EBItraining sequencing course is 22nd July!. It covers all qc and mapping steps, variant ca….
0
8
0
RT @Nature: Nature research paper: Asymmetric distribution of parental H3K9me3 in S phase silences L1 elements
0
27
0
RT @ODelaneau: New paper introducing RESHAPE, a method simulating genomes of hypothetical descendants that can be used as reference panels….
0
25
0
RT @inigo_landa: A common SNP at TERT c.-245T>C further increases TERT transcription and might refine the prognostic power of BRAF+TERT pro….
0
3
0